Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 2 of 21 for:    sotatercept

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (CADENCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04945460
Recruitment Status : Recruiting
First Posted : June 30, 2021
Last Update Posted : March 29, 2022
Information provided by (Responsible Party):
Acceleron Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : June 2025